Questions: B Vitamins as Coenzymes in Energy Metabolism

Question 1

An athlete takes high-dose B-vitamin supplements before competition, reasoning that B vitamins release energy from carbohydrates. What will actually happen?

• A. Performance improves — more coenzymes mean faster metabolic reactions
• B. No performance benefit — B vitamins enable energy-releasing reactions but are not energy sources themselves
• C. Performance decreases — excess B vitamins compete with normal coenzymes
• D. Beneficial only if the athlete is deficient; excess coenzymes are stored in muscle

Answer: (B)

B vitamins are coenzymes, not fuel. They enable enzymes to catalyze reactions but do not contribute calories or directly speed up metabolism beyond normal levels. If the athlete's B-vitamin status is already adequate, supplementation provides no additional benefit — the enzymes are already saturated with coenzyme. Option A reflects the common misconception that more coenzyme = more metabolic rate. Option D is partly right (deficiency is the only case where supplementation helps) but wrong about storage — excess water-soluble B vitamins are excreted, not stored in muscle.

Question 2

A patient with chronic alcoholism presents with elevated blood pyruvate and lactate, confusion, and abnormal eye movements. Which specific coenzyme deficiency explains the metabolic finding?

• A. FAD/FADH2 deficiency (riboflavin) — impairs the electron transport chain
• B. NAD+/NADH deficiency (niacin) — blocks glycolysis
• C. Thiamine pyrophosphate (TPP) deficiency — blocks pyruvate dehydrogenase, preventing pyruvate entry into the citric acid cycle
• D. Coenzyme A deficiency — prevents acetyl-CoA formation from any substrate

Answer: (C)

Thiamine pyrophosphate is the required coenzyme for pyruvate dehydrogenase. Without it, pyruvate cannot be converted to acetyl-CoA and accumulates, forcing conversion to lactate — producing the elevated pyruvate and lactate in the labs. The neurological findings (confusion, ophthalmoplegia, ataxia) are Wernicke's encephalopathy, the classic presentation of thiamine deficiency in alcoholics. FAD deficiency would impair the citric acid cycle and electron transport but would not specifically elevate pyruvate. NAD+ deficiency (pellagra) produces a different clinical picture.

Question 3

The distinctive clinical syndromes caused by thiamine, riboflavin, and niacin deficiencies reflect which specific metabolic reactions are blocked rather than a generic 'low energy' state.

• T. True
• F. False

Answer: True

This is the key clinical implication of coenzyme biochemistry. Each B vitamin's coenzyme form catalyzes specific reactions, so its absence creates a specific metabolic bottleneck. Thiamine deficiency blocks pyruvate dehydrogenase and α-ketoglutarate dehydrogenase — affecting aerobic glucose metabolism most severely, which is why brain and heart (exclusively aerobic) fail first. Niacin deficiency impairs NAD+-dependent reactions throughout glycolysis and the citric acid cycle, affecting high-turnover tissues (skin, gut, neurons) — causing the '3 D's' of pellagra. Understanding the coenzyme chemistry lets you predict these patterns rather than memorize them.

Question 4

Since B vitamins function as coenzymes that are regenerated (not consumed) in each catalytic cycle, the body does not require daily dietary intake of B vitamins in healthy adults.

• T. True
• F. False

Answer: False

B vitamins are recycled during catalysis — for example, NAD+ is regenerated after donating electrons — but they are not perfectly conserved. Coenzymes undergo degradation, are lost in urine, and are incorporated into other metabolic processes. Body stores are limited, especially for thiamine (only a few weeks' supply). Daily intake is required to maintain adequate tissue concentrations. This misconception arises from conflating 'recycled in each enzymatic cycle' with 'not needed from the diet' — the body recycles them functionally but still loses them over time.

Question 5

Why does thiamine deficiency cause neurological and cardiac symptoms specifically, rather than affecting all tissues equally? What does this reveal about the relationship between coenzyme specificity and clinical presentation?

Model answer: Brain and heart muscle are almost entirely dependent on aerobic glucose metabolism — they have minimal capacity to switch to fatty acid oxidation or anaerobic pathways for ATP. When thiamine pyrophosphate is deficient, pyruvate dehydrogenase stalls, blocking pyruvate from entering the citric acid cycle. Tissues that can use alternative fuels (skeletal muscle can use fatty acids, liver can perform gluconeogenesis) are somewhat protected. Neurons and cardiomyocytes cannot — they require continuous aerobic glucose metabolism, so they are the first to fail. A coenzyme deficiency's clinical severity in a given tissue depends on how exclusively that tissue relies on the blocked reaction.

The clinical specificity of B-vitamin deficiency syndromes is a direct consequence of coenzyme chemistry. Each coenzyme catalyzes defined reactions; each tissue has a defined metabolic repertoire; the overlap between 'which reactions are blocked' and 'which reactions a tissue depends on' determines vulnerability. This reasoning pattern — deficiency → blocked reaction → most dependent tissue fails first — is the analytical core of nutritional biochemistry.